The world is desperate to find a treatment that will save the lives of COVID-19 patients who come into the emergency room or hospital with low oxygen levels or are struggling to breathe. Started in March, 2020, as a ‹Working Group› of eight leading physicians, including five clinicians with over 200 years of combined experience in Critical Care and Emergency Medicine, who designed the MATH+ Hospital Treatment Protocol for COVID-19, our team, to date, is having remarkable success using MATH+ to treat patients in hospitals that permit its use. We are in the process of gathering patient data to scientifically prove that point. We changed our name to FLCCC Alliance because many other physicians are joining us in using most, if not all, of the MATH+ treatment medicines in their hospitals, and we hope to add their names here soon.

The administration of intravenous corticosteroids and ascorbic acid, starting in the emergency room and continued around the clock while the patient is in the hospital, greatly reduces the mortality rate of this disease and the need for mechanical ventilation. Furthermore, the inflammation caused by COVID-19 appears to cause high rates of blood clotting in multiple organs, necessitating the use of blood thinners.

Our core team of clinician scholars have not only the highest level of bedside expertise, but also have published more than 1,500 articles in peer-reviewed journals in the areas of corticosteroid and intravenous ascorbic acid use in critical illness, sepsis, and acute respiratory distress syndrome (ARDS). We discuss why the MATH+ protocol works against COVID-19 in the video below.